30 March 2007
A patient with both hairy cell leukemia and subacute thyroiditis
Ulku Ergene , Demircan Ozbalci , Huseyin AkinCase Rep Clin Pract Rev 2007; 8:102-105 :: ID: 476909
Abstract
Background: Hairy cell leukemia (HCL) presents with pancytopenia, splenomegaly, and monocyte-like hairy cells with eccentric nucleus in blood smear and bone marrow. Cladribine, pentostatin and interferon alpha are used for therapy. Fever is usually associated with infections of bacterial or
viral origin. High mortality and morbidity are associated with bacterial infections in those who are untreated.
Case Report: We report a 38 years old male HCL patient representing with fever and pain on the neck. The diagnosis of febrile neutropenia and subacute thyroiditis were made. For the therapy of subacute thyroiditis, paracetamol and propranolol were given. The patient had refused to take chemotherapy, so, when the thyroid function test reached the normal ranges, splenectomy was performed with the support of erythrocytes and platelet aphaeresis. At the follow up, the patient was in good state of health.
Conclusions: Subacute thyroiditis should be kept in mind especially in HCL representing with fever and pain over the thyroid. According to our search on medical database, this is the first reported case of HCL with subacute thyroiditis in literature.
Keywords: hairy cell leukemia, subacute thyroiditis, Splenectomy
657
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953543
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954216
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954932
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954146
Most Viewed Current Articles
07 Dec 2021 : Case report
28,712,695
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
180,721
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
124,419
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
08 May 2026 : Case report
95,462
DOI :10.12659/AJCR.952158
Am J Case Rep 2026; 27:e952158






